1. Home
  2. NPFD vs PRME Comparison

NPFD vs PRME Comparison

Compare NPFD & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Variable Rate Preferred & Income Fund

NPFD

Nuveen Variable Rate Preferred & Income Fund

HOLD

Current Price

$19.04

Market Cap

459.8M

Sector

Finance

ML Signal

HOLD

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$3.42

Market Cap

666.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPFD
PRME
Founded
2021
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
459.8M
666.1M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
NPFD
PRME
Price
$19.04
$3.42
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$6.42
AVG Volume (30 Days)
64.7K
3.8M
Earning Date
01-01-0001
11-07-2025
Dividend Yield
6.28%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,977,000.00
Revenue This Year
N/A
$111.80
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
647.13
52 Week Low
$14.50
$1.11
52 Week High
$18.07
$6.94

Technical Indicators

Market Signals
Indicator
NPFD
PRME
Relative Strength Index (RSI) 34.37 39.71
Support Level $19.04 $3.33
Resistance Level $19.15 $4.12
Average True Range (ATR) 0.11 0.24
MACD -0.01 -0.03
Stochastic Oscillator 5.45 13.08

Price Performance

Historical Comparison
NPFD
PRME

About NPFD Nuveen Variable Rate Preferred & Income Fund

Nuveen Variable Rate Preferred&Income is a diversified, closed-end management investment company. Its investment objective is to provide a high level of current income and total return. The fund invests a majority of its assets in variable-rate preferred securities and other variable-rate income-producing securities. The rest of its investments can be made in contingent capital securities or contingent convertible securities, convertible securities, corporate debt securities, U.S. government securities, residential and commercial mortgage-backed securities, fixed-rate preferred securities, senior loans and loan participations and assignments, sovereign debt instruments, debt securities issued by supranational agencies, and/or taxable and tax-exempt municipal bonds.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Share on Social Networks: